Lista de obras - Alberto Bosque - Dominio Público Uruguay

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.

artículo científico publicado en 2006

An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription

artículo científico publicado en 2014

An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients

artículo científico publicado en 2013

Apo2L/TRAIL and immune regulation.

artículo científico publicado en 2007

Apoptosis by IL-2 deprivation in human CD8+ T cell blasts predominates over death receptor ligation, requires Bim expression and is associated with Mcl-1 loss

article

Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation

article

BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.

artículo científico publicado en 2015

Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation.

artículo científico publicado en 2017

Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes

artículo científico publicado en 2008

Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein.

artículo científico publicado en 2016

Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells.

artículo científico publicado en 2012

Determinants for degradation of SAMHD1, Mus81 and induction of G2 arrest in HIV-1 Vpr and SIVagm Vpr.

artículo científico publicado en 2015

Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression.

artículo científico publicado en 2005

Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells

artículo científico publicado en 2014

Epigenetic regulation of HIV-1 latency by cytosine methylation

artículo científico publicado en 2009

Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients

artículo científico publicado en 2015

Fingolimod inhibits multiple stages of the HIV-1 life cycle

artículo científico publicado en 2020

Generation of rabbit antibodies against death ligands by cDNA immunization

artículo científico publicado en 2006

HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay

artículo científico publicado en 2016

HIV latency and integration site placement in five cell-based models.

artículo científico publicado en 2013

HIV-1 Latency and Latency Reversal: Does Subtype Matter?

scientific article published on 28 November 2019

HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response

artículo científico publicado en 2009

HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins

artículo científico publicado en 2015

Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells

artículo científico publicado en 2011

Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL

artículo científico publicado en 2005

Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.

artículo científico publicado en 2008

Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals

artículo científico publicado en 2020

Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells

artículo científico publicado en 2008

Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo

artículo científico publicado en 2016

Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.

artículo científico publicado en 2013

Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.

artículo científico publicado en 2018

Microbiota promotes systemic T-cell survival through suppression of an apoptotic factor

artículo científico publicado en 2017

Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.

artículo científico publicado en 2015

Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro

artículo científico publicado en 2017

Quantitative DY-maleimide-based proteomic 2-DE-labeling strategies using human skin proteins

artículo científico publicado en 2009

Reactivation of latent HIV-1 in central memory CD4⁺ T cells through TLR-1/2 stimulation

artículo científico publicado en 2013

Replication competent virus as an important source of bias in HIV latency models utilizing single round viral constructs

artículo científico publicado en 2014

Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL

artículo científico publicado en 2006

Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro.

artículo científico publicado en 2014

Structure activity relationship analysis of benzotriazine analogues as HIV-1 Latency Reversing Agents

scientific article published on 01 June 2020

Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells

artículo científico publicado en 2010

Sulfonation pathway inhibitors block reactivation of latent HIV-1.

artículo científico publicado en 2014

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

artículo científico publicado en 2017

The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation

artículo científico publicado en 2022

The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling

artículo científico publicado en 2006

Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.

artículo científico publicado en 2016

Lista de obras de Alberto Bosque

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.

An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription

An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients

Apo2L/TRAIL and immune regulation.

Apoptosis by IL-2 deprivation in human CD8+ T cell blasts predominates over death receptor ligation, requires Bim expression and is associated with Mcl-1 loss

Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation

BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.

Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation.

Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes

Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein.

Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells.

Determinants for degradation of SAMHD1, Mus81 and induction of G2 arrest in HIV-1 Vpr and SIVagm Vpr.

Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression.

Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells

Epigenetic regulation of HIV-1 latency by cytosine methylation

Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients

Fingolimod inhibits multiple stages of the HIV-1 life cycle

Generation of rabbit antibodies against death ligands by cDNA immunization

HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay

HIV latency and integration site placement in five cell-based models.

HIV-1 Latency and Latency Reversal: Does Subtype Matter?

HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response

HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins

Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells

Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL

Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.

Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals

Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells

Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo

Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.

Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.

Microbiota promotes systemic T-cell survival through suppression of an apoptotic factor

Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.

Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro

Quantitative DY-maleimide-based proteomic 2-DE-labeling strategies using human skin proteins

Reactivation of latent HIV-1 in central memory CD4⁺ T cells through TLR-1/2 stimulation

Replication competent virus as an important source of bias in HIV latency models utilizing single round viral constructs

Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL

Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro.

Structure activity relationship analysis of benzotriazine analogues as HIV-1 Latency Reversing Agents

Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells

Sulfonation pathway inhibitors block reactivation of latent HIV-1.

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation

The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling

Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.